Semaglutide
compound
This research monograph provides an in-depth analysis of semaglutide, a GLP-1 receptor agonist effective for type 2 diabetes management and weight loss. It discusses its pharmacological mechanisms, clinical applications, safety profile, and emerging evidence highlighting neuroprotective effects. Furthermore, it reviews preclinical and clinical data, pointing towards various ongoing trials and the compound's evolving role in metabolic medicine.
This research monograph provides an in-depth analysis of semaglutide, a GLP-1 receptor agonist effective for type 2 diabetes management and weight loss. It discusses its pharmacological mechanisms, clinical applications, safety profile, and emerging evidence highlighting neuroprotective effects. Furthermore, it reviews preclinical and clinical data, pointing towards various ongoing trials and the compound's evolving role in metabolic medicine.